Skip to main content
PLOS One logoLink to PLOS One
. 2021 Jul 26;16(7):e0254594. doi: 10.1371/journal.pone.0254594

Integral methods for automatic quantification of fast-scan-cyclic-voltammetry detected neurotransmitters

Leonardo X Espín 1,#, Anders J Asp 2,#, James K Trevathan 2, Kip A Ludwig 1, J Luis Lujan 1,3,*
Editor: Maria Asplund4
PMCID: PMC8312965  PMID: 34310610

Abstract

Modern techniques for estimating basal levels of electroactive neurotransmitters rely on the measurement of oxidative charges. This requires time integration of oxidation currents at certain intervals. Unfortunately, the selection of integration intervals relies on ad-hoc visual identification of peaks on the oxidation currents, which introduces sources of error and precludes the development of automated procedures necessary for analysis and quantification of neurotransmitter levels in large data sets. In an effort to improve charge quantification techniques, here we present novel methods for automatic selection of integration boundaries. Our results show that these methods allow quantification of oxidation reactions both in vitro and in vivo and of multiple analytes in vitro.

1 Introduction

Fast scan cyclic voltammetry (FSCV) is a powerful electrochemical sensing technique that allows quantification of variations in the concentration of electroactive neurochemicals by measuring redox currents resulting from the application of a periodic triangular waveform at a high scan rate [15]. Traditionally, FSCV has depended on the calculation of maximal oxidation currents, measured from known neurochemical concentrations in a solution, which are used to build calibration curves by using linear correlation techniques [610]. Recent studies have exploited the catecholamine adsorption properties of carbon fiber microelectrodes (CFM), to estimate basal concentrations of neurochemicals [1114]. Techniques including fast scan cyclic adsorption voltammetry (FSCAV) use oxidation-charge measurements, rather than maximal currents, which are obtained by time-integrating cyclic voltammograms within intervals containing single oxidation peaks (or “humps”) [1113]. However, the accuracy and reproducibility of oxidation-charge measurements are limited by visual selection of integration bounds of the cyclic voltammogram oxidation peaks. In practice, defining which portion of the voltammogram constitutes an oxidation peak (where it begins, and where it ends) is obscured by the noise floor of the dataset, the electrochemical interferents, the presence of artifacts, and background drift. Visual selection leads to ambiguity, introduces additional sources of error and precludes the development of automated procedures necessary for analysis and charge quantification in large data sets.

Here, we describe novel charge quantification techniques by performing automatic selection of integration boundaries. This is achieved by analyzing and identifying voltammogram’s critical, inflection and maximum curvature points, to allow the automatic selection of integration intervals. We test these techniques in both in vitro and in vivo experimental scenarios.

2 Methods

2.1 In vitro data collection

The Mayo Clinic Institutional Animal Care and Use Committee (IACUC) has reviewed and approved this research. Anesthesia and euthanasia were performed per Mayo Clinic IACUC regulations with urethane and fatal plus, respectively. In vitro data collection was performed using a FIAlab 3200 flow injection system (FIAlab Instruments, Seattle, WA) and the WINCS Harmoni device [15]. A CFM of 7μm diameter and110μm in length was placed in a flowing stream of artificial cerebrospinal fluid (aCSF) buffer solution with a pH value of 7.4 as described previously [15]. For each measurement, buffered aCSF solutions containing 0.1 μM to 5 μM of either dopamine, adenosine, epinephrine, or norepinephrine (Millipore Sigma, Burlington, MA) were injected for 8 s at 2.25 mL/min. The in vitro data was collected using two electrodes, with 3–15 injections per analyte.

2.2 In vivo data measurements

In vivo measurements were obtained in a rodent model of medial forebrain bundle stimulation and simul- taneous FSCV recording in the dorsal striatum as described previously [15]. Rats were sedated prior to surgery with intraperitoneal urethane (1.5 g/kg in a 0.26 g/mL saline solution, Millipore Sigma, Burling- ton, MA). Analgesia was maintained for rodents with intramuscular buprenorphine (0.06 mg/kg). Both the stimulation electrode and CFM were stereotactically inserted (KOPF instruments, Tujunga, CA). A scalp incision (1.5–2.0 cm) was made to expose the skull, and three trephine burr holes (approximately 3 mm in diameter) were drilled to allow implantation of the stimulating, neurochemical sensing, and reference electrodes. Dopamine release was evoked with a series 2 s stimulations using a range of amplitudes from 0.05–2.0 mA and pulsewidths from 0.8 and 1.8 ms, presented in a randomized order such that effects of hysteresis are minimized. Analyte measurements were obtained by sweeping the CFM potential from a resting potential of -0.4 V to a switching potential of 1.5 V and back to the resting potential, at a rate of 400 V/s every 100ms.

2.3 Charge quantification

We define the charge resulting from a single oxidation/reduction reaction by

Q=xlxrBtdt, (1)

where B(t) is a background subtracted voltammogram, and we assume that the integration interval [xl xr] contains a single oxidation/reduction peak (Fig 1a). In this study we use four pairs of integration boundaries (Fig 1) to quantify charge. When there is little or no background drift, indicating a stable background capacitive current, the faradaic current response on a background subtracted voltammogram decays towards zero away of the maximum oxidation current [16]. “True” integration boundaries are defined as the points around an oxidation peak where the current is zero (Fig 1a). Charges computed with true boundaries provide a useful benchmark for comparing quantification methods. However, “True” limits as defined here are unavoidably confounded by the interplay between the Gaussian dopamine oxidation peak and the noise levels in the recording; as a Gaussian distribution never decays to zero.

Fig 1.

Fig 1

a) Background subtracted voltammogram for a bolus of a 0.5 μM dopamine solution. True (“o”, xl = 0.26 V and xr = 1.5 V), FSCAV (“♦”, xl = 0.4 V and xr = 0.9 V), inflection (“+”, xl = 0.41 V and xr = 0.68 V) and curvature integration boundaries (“x”, xl = 0.29 V and xr = 0.76 V) are marked on the voltammogram. b) Second derivative of the voltammogram shown in (a), showing the definition of inflection boundaries (inflection points), and curvature boundaries (the maxima around the location of the oxidation peak). c) Flow chart demonstrating overview of applied computational procedures to raw FSCV data.

FSCAV limits (Fig 1a), correspond to the ad-hoc voltages (0.4 V and 0.9 V) selected as integration limits for the quantification of dopamine [13]. Note that all measurements were collected using a traditional FSCV waveform described in section 2.2 as opposed to FSCAV. Inflection limits are defined as the zeros of the second derivative of a voltammogram, around an oxidation (or reduction) peak, and curvature points (maximum curvature, or maximum second derivative) are defined as the maxima/minima of the second derivative around an oxidation/reduction peak, see Fig 1(b).

Computational routines for filtering and smoothing background- subtracted voltammograms, as well as to calculate higher order derivatives, to find, classify, sort and correct curvature and inflection points are implemented in MATLAB (Fig 1). A 1000Hz lowpass 2nd phase butterworth filter was applied to all data in both forward and reverse directions to reduce spurious signals. Data was also smoothed with a 5-point moving average and a CSAPS Cubic smoothing spline before background subtraction subsequent charge calculations. Correction routines require not adding negative areas to the total charge in the case of oxidation reactions, and have the switching potential as hard limit for xr. Similar considerations are utilized for reduction-charge calculations (excluding regions with positive areas, and using the switching potential as hard limit for xl).

3 Results and discussion

3.1 Quantification of in vitro catecholamines

In Fig 2 we show (a) true and (b-c) curvature integration boundaries obtained with our algorithms. As a reference we also show the location of the maximum oxidation currents with dots, and panels (b- c) show the FSCAV integration limits taken from reference [11], 0.4 V and 0.9 V with vertical dashed lines. The data for panels (a) and (b) corresponds to background subtracted voltammograms of a flow cell experiment, where 70 dopamine injections with 0.1, 0.5 and 1 micromolar were done. The data for panel (c) corresponds to voltammograms of a flow cell experiment, where 15 norepinephrine injections with 0.1, 0.5, 1 and 5 micromolar were done.

Fig 2.

Fig 2

a) True integration limits (“x”) and maximum oxidation currents (dots) obtained from a flow cell experiment consisting of 70 dopamine injections at different concentrations. b) Curvature integration boundaries (“+”) for the experimental data of (a). c) Curvature boundaries for a flow cell experiment with 15 norepinephrine injections at different concentrations. FSCAV limits are shown with dashed vertical lines. Quantities shown in the figure indicate averages ± standard deviations.

Panels (a) and (b) of Fig 2 show that the curvature boundaries select narrower integration intervals than true boundaries. However, it is interesting to note that curvature boundaries show less variability than the true boundaries (average voltages and standard deviations are shown in Fig 2). This is unex- pected given that the computation of curvature boundaries involves calculating higher-order derivatives of voltammograms, which should amplify noise [17], and as a consequence curvature boundaries variability.

Because of the visual similarities between typical dopamine and norepinephrine background subtracted voltammograms [4,11,18], comparisons using norepinephrine data are particularly useful, because they highlight the limitations of using visual identification to obtain integration boundaries. Indeed, panels (b) and (c) of Fig 2 indicate that there is a significant difference between average left curvature boundaries for dopamine and norepinephrine voltammograms.

Indeed, Fig 3 shows oxidation-charge calculations with the four pairs of integration boundaries intro-duced in section 2.3. Panel (a) shows calculations for the dopamine dataset corresponding to (Fig 2a and 2b), and panel (b) shows calculations for the norepinephrine dataset corresponding to Fig 2(c). Fig 3(a) shows that when quantifying dopamine charge, the ad-hoc FSCAV limits and curvature are not significantly different at concentrations greater than 0.1μM as demonstrated by a comparison of mean curvature and FSCAV datapoints using an ANOVA with Holm-Sidak comparison for multiple corrections, P>0.05 n.s. However, despite shape similarities between dopamine and norepinephrine background subtracted voltammograms (e. g. correlation coefficient > 0.86, see [18,19]), oxidation charges obtained with curvature limits provide a closer approximation to true charges than FSCAV limits at concentrations of 1μM and greater, as demonstrated by a comparison of mean curvature and FSCAV datapoints using an ANOVA with Holm-Sidak comparison for multiple corrections (at 0.5μM, curvature (20.58±0.99) v. FSCAV(19.48±0.88), P = 0.1087 n.s.; at 1μM, curvature (86.84±2.21) v. FSCAV(75.57±1.76), P<0.0001 ****; at 5μM, curvature (27.23±0.6) v. FSCAV(24.88±0.0.56), P<0.01 ****) (Fig 3b).” Consequently, all analyses of charge in subsequent figures are performed using the curvature method in the interest of focus and clarity.

Fig 3.

Fig 3

a) Oxidation charges for the data shown in (Fig 2a and 2b), obtained with different integration boundaries. b) Oxidation charges for the data shown in Fig 2(c), obtained with different integration boundaries. Averages and standard deviations for charges using true, FSCAV (in italic) and curvature (bold) integration boundaries are also shown. Quantities shown in the figure indicate averages ± standard deviations.

Curvature integration boundaries provide the highest charge among the three methods considered at concentrations above 0.5 μM as shown by a comparison of curvature and FSCAV datapoints using an unpaired two-tailed t-test with welch’s correction (0.1μM, p>0.05; 0.5μM, p = .024; 1μM, p = .0001; 5 μM, p = .0003) (Fig 4).”As illustrated by Fig 4(a), epinephrine voltammograms have two oxidation peaks [3], and if we try to calculate the oxidation charge due to the primary (or secondary) peak alone, true boundaries produce erroneous results by selecting a region that contains both oxidation peaks. This issue also arises when combinations of analytes (like dopamine and adenosine) are being measured.

Fig 4.

Fig 4

a) A 1 μM epinephrine voltammogram showing primary and secondary oxidation peaks, superimposed with curvature and true integration limits. b) Primary-peak oxidation charges for a flow cell experiment with 15 injections of epinephrine at different concentrations, obtained with different pairs of integration limits. Averages and standard deviations for charges using FSCAV (in italic) and curvature (bold) integration boundaries are also shown. Quantities shown in the figure indicate averages ± standard deviations.

3.2 Charge quantification of in vivo measurements

Rapid changes in the brain electrochemistry can lead to faster background current drift [2,20,21], which distorts the voltammograms (an example is shown in Fig 5a). The use of true charges as a benchmark for charge quantification depends on the stability of the background current measured with FSCV. Thus, faster in-vivo background-current change can pose a problem for the use of true boundaries with in-vivo data, as we explain below. Fig 5(a) shows a stimulation-evoked background-subtracted voltammogram from a rodent striatum dopamine measurement evoked by systematically varying amplitude and duty cycle applied in a random order to minimize hysteresis., superimposed with curvature boundaries. A region of positive, nearly constant current between 1 and 1.5 volts that persists far into the cathodic sweep, is likely the consequence of background drift. Drift is exacerbated by disruption of Helmholtz layer or pH changes as a result of electrical stimulation [22]. The integration boundaries can still be calculated in the presence of background drift, though the exact cutoffs may be affected. It is generally advisable for the experimenter to minimize any possible sources of background drift or other redox sources in FSCV recordings for consistent data analysis and interpretation. The shaded region adds a positive bias to the charge computed with true boundaries. Furthermore, a similar behavior is observed in most voltammograms of the data set of Fig 5. Consequently, in panel (b), which shows true and curvature boundaries for the entire dataset, the right true boundary xr has been set to the switching potential of the voltage sweep.

Fig 5.

Fig 5

a) Background subtracted voltammogram of a dopamine signal taken from a rat during DBS of the medial forebrain bundle (0.14mA, 1.43ms pulse width, 180 pulses, 90Hz), superimposed with squares showing the curvature boundaries for the voltammogram. Charge in the shaded region is likely the result of background current drift. Stimulation amplitude and pulse widths ranging from 0.14–0.16ms and 1.37–1.57ms, respectively, were systematically applied in a random order to minimize effects of hysteresis. All stimulation epochs consisted of 180 pulses delivered at 90Hz b) True and curvature boundaries obtained from background subtracted voltammograms of the entire rat DBS dataset with random combinations stimulation.

We contrast the behavior of true boundaries for the experimental data set of Fig 5(b) with that of the curvature boundaries, which despite the random variation of the DBS stimulation parameters of the experiment, show little variability (xl = 0.388 ± 0.007 V and xr = 0.807 ± 0.022 V), demonstrating the robustness of our charge quantification algorithms.

This robust behavior can be utilized for outlier detection purposes. Values that deviate the most from the average right curvature boundary of the voltammograms in (xr = 0.807 ± 0.022 V) Fig 5(a) indicate that stimulation artifacts have altered the shape of the voltammograms and the corresponding curvature boundaries have adapted to the shape of each curve 6(a). Here, details of the oxidation-hump region of three voltammograms are shown with their corresponding curvature boundaries indicated by asterisks, demonstrating that the integration limits can be objectively determined with varying stimulation parameters, even in the presence of sources of noise such as a stimulation artifact.

In Fig 6(b) we present the oxidation charges corresponding to the in-vivo experimental data set of Fig 5, as function of the stimulation duty cycle. This panel shows how the response measured by the CFM increases as a function of the increasing stimulation duty cycle.

Fig 6.

Fig 6

a) Voltammogram regions enclosing the oxidation peak of selected background subtracted voltammograms taken from the data set of Fig 5, superimposed with asterisks showing the curvature boundaries for each voltammogram. Stimulation parameters for the traces X,Y, and Z are as follows X: 0.14mA, 1.46ms pulse width, 180 pulses, 90Hz Y: 0.16mA, 1.57ms pulse width, 180 pulses, 90Hz Z: 0.15mA, 1.45ms pulse width, 180 pulses, 90Hz (b) Oxidation charges corresponding to the data set of Fig 5, obtained with curvature limits, plotted as function of the duty cycle for the 90 Hz, two-second stimulations.

3.3 Quantifying charge produced in reduction reactions

As described in section 2.3, our methods can be used to quantify charged due to reduction reactions, and our algorithms require minimal alterations to do so (finding minima instead of maxima, etc).

Fig 7(a) shows the curvature limits for the reduction dips measured in the data set of Fig 3(a). Fig 7(b) we show the corresponding charges obtained with curvature limits, as well as with inflection limits. We note that for reduction reactions, very often a right true limit is not existent (see Fig 8(a) for an example). In consequence charges obtained with true limits are not shown.

Fig 7.

Fig 7

a) Curvature integration limits for the reduction dips of the data set of Fig 3(a). Minimum reduction currents are shown with asterisks. b) Reduction charges (absolute value) for the data set of Fig 3(a), obtained with inflection and curvature (bold) integration boundaries. Quantities shown in the figure indicate averages ± standard deviations.

Fig 8.

Fig 8

a) Background subtracted voltammogram showing two oxidation peaks due to 1 μM dopamine plus 1 μM adenosine, along with the corresponding curvature boundaries for each peak: 0.33 V and 0.79 V for DA, and 1.31 V and 1.5 V for ADO. b) Background subtracted voltammogram showing two oxidation peaks due to 0.5 μM epinephrine, and the corresponding curvature boundaries for each peak: 0.38 V and 0.80 V for first peak, and 1.25 V and 1.5 V for the second. Vertical dashed lines indicate the switching potentials.

3.4 Quantifying charge in voltammograms with multiple oxidation peaks

If multiple electroactive analytes are present in a FSCV measurement, quantifying oxidation due to different species can be challenging. In this section we illustrate how our quantification techniques can aid in that task, when used with cyclic voltammograms displaying multiple humps. Linear charge calibration data for dopamine, adenosine, and a solution of dopamine+adenosine were calculated using true, inflection, and curvature integration boundaries (S1 Fig). Indeed, the definitions of curvature limits and inflection limits can be used for individual oxidation humps, as we show in Fig 8, where two examples of multiple-oxidation-hump voltammograms, as well as curvature boundaries for each peak are displayed. Notice that in Fig 8(a) the two peaks appear because of two different species, while the voltammogram of Fig 8(b) is the result of the oxidation of epinephrine (see also Fig 4(a)).

3.5 Challenges and limitations

While this approach may be helpful for standardizing oxidation charge quantification of electroactive neurochemicals, it is not without limitations. The relationship between charge and analyte concentration is nonlinear (Fig 3). While linear regressions are regularly used when creating a calibration curves [610], this approach may result in underestimations at the low and high ends of detectable concentrations while overestimations concentrations at the midpoint of the detectible range. Fitting with a nonlinear regression model may reduce these errors when converting between charge and concentration for unknown samples. Furthermore, we present a limited analysis of the performance of automated charge calculation methods in a sample of multiple analytes, but a more exhaustive characterization of charge in the presence of other electroactive interferents (e.g. DOPAC, Guanine, Serotonin, etc.) is necessary to fully determine performance of this approach. Despite these limitations, computational approaches such as the one described here are necessary for improving accuracy and consistency of electroactive neurochemical measurements.

4 Conclusions

Here, we propose novel methods to quantify charge from REDOX reactions observed in voltammetric measurements electroactive neurochemicals. While our proposed methods were applied to a dataset collected with a traditional FSCV waveform, this approach can be generalized to other voltammetric waveforms reliant on charge quantification, including FSCAV. However, additional studies must be completed to characterize behavior of our approach with novel voltammetric waveforms. Although a definitive selection of integration boundaries is confounded by interferents, background drift, low signal to noise ratio, and other effects, data shown here suggest that our quantification methods are comparable to competing methods for quantification of dopamine oxidation charge, and may more closely approximate true charge when applied to other catecholamines. Additionally, unlike existing charge quantification techniques, our methods can quantify reduction reactions as well as single oxidation or reduction peaks when multiple analytes are present in a sample. Here, charge analysis has been performed automatically, improving reproducibility and demonstrating the feasibility of developing automated routines for charge quantification of multiple analytes.

Supporting information

S1 Fig. Linear charge calibration curve for dopamine, adenosine, and dopamine +adenosine using a)True integration limits b) curvature integration limits, and c) inflection integration limits at concentrations of 0.1 μM, 0.5 μM, and 1 μM.

Data are fit with a linear regression and R2 values are displayed for each analyte.

(DOCX)

Data Availability

Data and code are available on GitHub (https://github.com/aspanders/FSCVIntegralMethods).

Funding Statement

This work was funded by the National Institutes of Health grant R01 NS084975 awarded to J. Luis Lujan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nih.gov/.

References

  • 1.Wightman R. M., Amatorh C., Engstrom R. C., Hale P. D., Kristensen E. W., Kuhr W. G., et al. , “Real-time characterization of dopamine overflow and uptake in the rat striatum,” Neuroscience, vol. 25, no. 2, pp. 513–523, 1988. doi: 10.1016/0306-4522(88)90255-2 [DOI] [PubMed] [Google Scholar]
  • 2.Robinson D. L., Hermans A., Seipel A. T., and Wightman R. M., “Monitoring rapid chemical com- munication in the brain,” Chemical Reviews, vol. 108, no. 7, pp. 2554–2584, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Heien M. L., Johnson M. A., and Wightman R. M., “Resolving neurotransmitters detected by fast-scan cyclic voltammetry,” Analytical Chemistry, vol. 76, no. 19, pp. 5697–5704, 2004. doi: 10.1021/ac0491509 [DOI] [PubMed] [Google Scholar]
  • 4.Robinson D. L., Venton B. J., Heien M. L., and Wightman R. M., “Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo,” Clinical Chemistry, vol. 49, no. 10, pp. 1763–1773, 2003. doi: 10.1373/49.10.1763 [DOI] [PubMed] [Google Scholar]
  • 5.Wipf D. O., Michael A. C., and Wightman R. M., “Microdisk electrodes. part ii. fast-scan cyclic voltammetry with very small electrodes,” Journal of Electroanalytical Chemistry, vol. 269, no. 1, pp. 15–25, 1989. [Google Scholar]
  • 6.Logman M. J., Budygin E. A., Gainetdinov R. R., and Wightman R., “Quantitation of in vivo measurements with carbon fiber microelectrodes,” Journal of Neuroscience Methods, vol. 95, no. 2, pp. 95–102, 2000. doi: 10.1016/s0165-0270(99)00155-7 [DOI] [PubMed] [Google Scholar]
  • 7.Wiedemann D. J., Kawagoe K. T., Kennedy R. T., Ciolkowski E. L., and Wightman R. M., “Strategies for low detection limit measurements with cyclic voltammetry.,” Analytical chemistry, vol. 63, no. 24, pp. 2965–70, 1991. doi: 10.1021/ac00024a030 [DOI] [PubMed] [Google Scholar]
  • 8.Lu Y., Peters J. L., and Michael A. C., “Direct comparison of the response of voltammetry and microdialysis to electrically evoked release of striatal dopamine,” Journal of neurochemistry, vol. 70, no. 2, pp. 584–593, 1998. doi: 10.1046/j.1471-4159.1998.70020584.x [DOI] [PubMed] [Google Scholar]
  • 9.Kawagoe K. T., Garris P. A. T., and Wightman R. M., “ph-dependent processes at nafion-coated carbon-fiber microelectrodes,” Journal of Electroanalytical Chemistry, vol. 359, no. 1–2, pp. 193–207, 1993. [Google Scholar]
  • 10.Jackson B. P., Dietz S. M., and Wightman R. M., “Fast-scan cyclic voltammetry of 5- hydroxytryptamine,” Analytical Chemistry, vol. 67, no. 6, pp. 1115–1120, 1995. [DOI] [PubMed] [Google Scholar]
  • 11.Atcherley C. W., Laude N. D., Parent K. L., and Heien M. L., “Fast-scan controlled-adsorption voltammetry for the quantification of absolute concentrations and adsorption dynamics,” Langmuir, vol. 29, no. 48, pp. 14885–14892, 2013. doi: 10.1021/la402686s [DOI] [PubMed] [Google Scholar]
  • 12.Atcherley C. W., Wood K. M., Parent K. L., Hashemi P., and Heien M. L., “The coaction of tonic and phasic dopamine dynamics,” Chemical Communications, vol. 51, no. 12, pp. 2235–2238, 2015. doi: 10.1039/c4cc06165a [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Burrell M. H., Atcherley C. W., Heien M. L., and Lipski J., “A novel electrochemical approach for prolonged measurement of absolute levels of extracellular dopamine in brain slices,” ACS Chemical Neuroscience, vol. 6, no. 11, pp. 1802–1812, 2015. doi: 10.1021/acschemneuro.5b00120 [DOI] [PubMed] [Google Scholar]
  • 14.Oh Y., Park C., Kim D. H., Shin H., Kang Y. M., DeWaele M., et al. , “Monitoring in vivo changes in tonic extracellu- lar dopamine level by charge-balancing multiple waveform fast-scan cyclic voltammetry,” Analytical Chemistry, vol. 88, no. 22, pp. 10962–10970, 2016. [DOI] [PubMed] [Google Scholar]
  • 15.Lee K. H., Lujan J. L., Trevathan J. K., Ross E. K., Bartoletta J. J., Park H., et al. , “Wincs harmoni: Closed-loop dynamic neurochemical control of therapeutic interventions,” Nature Scientific Reports, 2017. doi: 10.1038/srep46675 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Phillips P. E. M., Robinson D. L., Stuber G. D., Carelli R. M., and Wightman R. M., “Real-time measurements of phasic changes in extracellular dopamine concentration in freely moving rats by fast-scan cyclic voltammetry,” Methods Mol Med, vol. 79, pp. 443–464, 2003. doi: 10.1385/1-59259-358-5:443 [DOI] [PubMed] [Google Scholar]
  • 17.Oppenheim A. V., Willsky A. S., and Nawab S. H., Signals and Systems (2Nd Ed.). Upper Saddle River, NJ, USA: Prentice-Hall, Inc., 1996. [Google Scholar]
  • 18.Park J., Takmakov P., and Wightman R. M., “In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry,” Journal of Neurochemistry, vol. 119, no. 5, pp. 932–944, 2011. doi: 10.1111/j.1471-4159.2011.07494.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Heien M. L. A. V., Khan A. S., Ariansen J. L., Cheer J. F., Phillips P. E. M., Wassum K. M., et al. , “Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats.,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 29, pp. 10023–8, 2005. doi: 10.1073/pnas.0504657102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Robinson D. L., Venton B. J., Heien M. L., and Wightman R. M., “Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo,” Clinical Chemistry, vol. 49, no. 10, pp. 1763–1773, 2003. doi: 10.1373/49.10.1763 [DOI] [PubMed] [Google Scholar]
  • 21.Jang D. P., Kim I., Chang S. Y., Min H.-K., Arora K., Marsh M. P., et al. , “Paired pulse voltammetry for differentiating complex analytes.,” The Analyst, vol. 137, no. 6, pp. 1428–35, 2012. doi: 10.1039/c2an15912k [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Takmakov P., Zachek M.K., Keithley R.B., Bucher E.S., McCarty G.S., and Wightman R.M., "Characterization of Local pH Changes in Brain Using Fast-Scan Cyclic Voltammetry with Carbon Microelectrodes," Anal. Chem., vol.82, pp. 9892–9900, 2010. doi: 10.1021/ac102399n [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Maria Asplund

27 Oct 2020

PONE-D-20-25050

Integral methods for automatic quantification of fast-scan-cyclic-voltammetry detected neurotransmitters

PLOS ONE

Dear Dr. Asp,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Both reviewers agree on the importance of your work, but also raised many important questions that need to be clarified. Please consider each point carefully in your revision and make it clear how you addressed each of these points in your revised version.

Please submit your revised manuscript by Dec 11 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Maria Asplund, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This study discusses the development of a novel methodology for selecting integration limits for the purpose of quantifying the concentration of electrochemical targets using FSCV. This technology advancement could serve as a critical improvement to the in vivo basal detection method FSCAV by replacing user-defined integration limits with algorithm-defined cutoffs. This would have the desired effect of removing the possibility for user bias from FSCAV data analysis. This study is highly relevant but requires substantial revision prior to publication.

Major

• How does the curvature method perform when dealing with small in vivo oxidation peaks resulting from FSCAV basal detection or brief DBS stimulation? The authors state that the desired use for is for this methodology is to provide cutoff limits for in vivo FSCAV experiments. This study should show the applicability of the methodology using FSCAV data.

• The responses in Figure 3 display varying degrees of linearity (none of them highly linear). Please discuss the consequences of this given that linear regression of these responses is used to convert between charge and concentration for unknown samples. Does the degree of linearity for the various methods adjust the determination of which method is best suited for use?

• Please provide detailed statistical analysis between groups to support claims. For example, the author’s claim that there is a “significant difference between average left curvature boundaries for DA and NEP” is not supported by statistical evidence.

• There are many cases where the authors neglect discussing data sets within the figures. For example, the authors largely neglect discussing the data arising from the inflection method throughout the entire manuscript as well as the FSCAV limits for EPI. Please discuss all relevant data provided in the figures.

• The authors state that “A region of positive, nearly constant current between 1 and 1.5 volts that persists far into the cathodic sweep is likely the consequence of background drift.” Is there evidence to support that claim? If the feature is drift, why does that drift not occur prior to the oxidation peak (-0.4 V to 0.3 V)?

• What is meant by the “random variation of the DBS stimulation parameters” in the main text when describing the data in Figure 5. Were these data collected using the various duty cycles detailed in Figure 6? What set of conditions were used to produce the response in Figure 5a?

• Are the results detailed in Figure 6b meant to state that the increase in the charge is due to an increase in the extracellular concentration of the in vivo chemical (I assume the chemical is dopamine but the authors never state the identity of the in vivo signal) or is this a consequence of the duty cycle artifact on integration limits? In addition, the authors neglect discussing how the data seem to group by stimulation current as well. Please substantially revise and clarify this discussion.

• It is unclear why the authors would want to optimize quantifying stimulation artifacts in Figure 6. Stimulation timing is routinely staggered with FSCV recordings to ensure that artifacts do not distort background subtracted voltammograms. Please explain.

• The 2nd EPI peak in Figure 8b has clearly not resolved by the switching potential. Cutting at the switching potential does not seem appropriate for obtaining an accurate quantification of the 2nd peak. Is this technique only applicable for targets where the peaks are allowed to totally resolve prior to the switching potential?

• How does the sensitivity for target (DA) detection in the presence of interferent compare to the sensitivity for target alone using the various methods? This is critical to assessing the selectivity of the technique. Please provide the linear calibration data for DA in the presence of interferent (Figure 8a) and compare to response with DA alone.

Minor

• Please state the specific “computational routines for filtering and smoothing” used in this study.

• How many individual electrodes were tested for both in vitro and in vivo testing? How many animals were used for in vivo testing?

• How is “accuracy” determined when comparing calculated charges from FSCAV limits and curvature limits to the “True Charges”? Does this refer to linear sensitivity? Please be more specific.

• It is notable that the DA, NEP and EPI experiments in Figures 2, 3 and 4 reflect different experimental designs. Why was NEP and EPI tested up to 5 µM whereas DA was only tested to 1 µM? Why were there so few replicates for NEP and EPI as compared to DA? If the authors intend to provide a fair comparison between the responses of various chemicals then the experimental protocols should mimic each other.

• The authors state that “Figure 4 shows an example were curvature integration boundaries provide the best results among the four methods considered”. I only see 3 methods represented (please include the “True” results. Also, what does “best results” mean?

• Please show the peak shape for NEP since the peak shape is shown for DA and EPI.

• Why are average values for the inflection method not displayed on Figures 3 and 4?

• Please provide markings for all four of the limits on Figure 4a (similar to Figure 1a)

• The a) and b) labeling on Figures 1 and 5 are not consistent with the other figures.

• How do the in vivo limits compare to the previous limits defined by FSCAV? Please incorporate those cutoff values into Figures 5a and 5b.

• Average ± What? Is it standard deviation? Standard error?

• What do the numbers in the legend of Figure 6a stand for?

• The authors state that there cannot be a “True Limit” for the reduction peak. They previously stated that the switching potential could serve as a limit for the “True” method in cases where the peak does not return to zero (i.e. in vivo data). Wouldn’t this justification be applicable here as well and allow for inclusion of the “True” data set into Figure 7?

• It is confusing why the two background-subtracted voltammograms for EPI (Figure 4a and Figure 8b) look so different. Are they at different concentrations? Why is the ratio of the two oxidation peak heights so drastically different between the two responses?

Reviewer #2: This paper presents a novel approach to identify neurochemicals and a clever effort to reduce false observations in FSCV or FSCAV data. Given that most of voltammetric post-analysis methods are prone to misinterpretation, a more mathematical approach – like the one presented in this work – can contribute to making more accurate statements on the collected biological data. It would be interesting to see how this work would develop in future.

The paper is well written and the title fits the premises of the target study. I have several rather technical comments to further improve the clarity of the presented method/results (listed here in the order of appearance).

Abstract-------------------------------

1. In the last paragraph, the authors claimed, “Our results show that these methods allow quantification of oxidation and reduction reactions, for multiple analytes, both in vitro and in vivo.” however:

a) the provided results in the manuscript do not fully address in vivo quantification of the reduction reactions (pages 10,3.3). Please correct the text or include more data to support the claim.

b) the provided data in the manuscript do not support the claim on detection of “multiple analytes” in vivo (see page 10, section 3.2, Figure 6). Please amend the text to better reflect the result or include more data to support the text.

Method--------------------------------

2. Please specify what is meant by “A 110 µm CFM”. Both the length and diameter of the used electrode should be provided (page 2, 2.1)

3. The authors have presented this work as an automatic quantification approach however, the manuscript is missing details on how theses boundary conditions were implemented into an automatized system. Authors should support the concept with a schematic flowchart/algorithm of the applied “routines”. The flowchart should provide an overview of the applied computational procedure for filtering/smoothing and background- subtractions in addition to the correction routines (page 5, 2.3).

Results and discussion-------------------------------

4. According to the manuscript, 70 injections of DA and 15 injections of norepinephrine were applied to produce the results (page 5, 3.1). However, it is not clear how many electrodes were used to generate the presented data. Please provide the sample size, i.e. number of electrodes in addition to the number of injections per electrode, for the presented results.

5. Statistical analysis (including the level of significance) should be included to support the presented comparisons. An optical judgment is indeed a good cue but not sufficient for deciding on the efficacy of the presented method. Here are some example statements which should be statistically backed up:

“In Figure 4 shows an example were curvature integration boundaries provide the best results among the four methods considered” (page 8, 3.1).

“Figure 3(b) shows that oxidation charges obtained with curvature limits provide a better approximation to true charges than FSCAV limits.” (page 7, 3.1)

“…curvature boundaries select a wider region than that enclosed by the injection boundaries (figure 1), and they provide a better approximation to the charges obtained by using true boundaries,..” (page 7, 3.1)

6. Please include one paragraph discussing the limitations and challenging aspects of the proposed approach.

----------------------------------------------------------------

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jul 26;16(7):e0254594. doi: 10.1371/journal.pone.0254594.r002

Author response to Decision Letter 0


28 Apr 2021

All comments have been addressed in the revised manuscript and "response to reviewers" document. Thank you for your consideration.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Maria Asplund

29 Jun 2021

Integral methods for automatic quantification of fast-scan-cyclic-voltammetry detected neurotransmitters

PONE-D-20-25050R1

Dear Dr. Asp,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. As a final improvement to your paper, please consider the comment from Reviewer 1 regarding the figure formatting (colours and font size)

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Maria Asplund, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have adequately addressed my concerns, and as a result the manuscript is much improved.

My only remaining comment is regarding the formatting of figures. The text on the figures is difficult to read at times due to either the small font, grey text coloring or a combination of both. Please adjust the figure text so that it is easier to read.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Maria Asplund

14 Jul 2021

PONE-D-20-25050R1

Integral methods for automatic quantification of fast-scan-cyclic-voltammetry detected neurotransmitters

Dear Dr. Asp:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Maria Asplund

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Linear charge calibration curve for dopamine, adenosine, and dopamine +adenosine using a)True integration limits b) curvature integration limits, and c) inflection integration limits at concentrations of 0.1 μM, 0.5 μM, and 1 μM.

    Data are fit with a linear regression and R2 values are displayed for each analyte.

    (DOCX)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    Data and code are available on GitHub (https://github.com/aspanders/FSCVIntegralMethods).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES